References
Jan 1, 1988·Schizophrenia Bulletin·T H McGlashan
Jun 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·T R Barnes, D A Curson
Mar 17, 1999·Archives of General Psychiatry·D RobinsonJ A Lieberman
Apr 30, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Dawn I VelliganAlexander L Miller
Sep 10, 2003·Journal of the American Academy of Dermatology·Kimberly HersomJohn S Strauss
Mar 1, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Neeltje E M van HarenRené S Kahn
May 29, 2009·Cost Effectiveness and Resource Allocation : C/E·Douglas E FariesHaya Ascher-Svanum
Dec 5, 2009·Schizophrenia Research·David HoughMariëlle Eerdekens
Jul 10, 2010·Journal of Psychopharmacology·S GopalD Hough
Sep 23, 2010·Journal of Psychiatric Practice·Dawn I VelliganJohn P Docherty
Jan 25, 2011·Schizophrenia Research·Claudia LeuchtStefan Leucht
Mar 3, 2011·The American Journal of Psychiatry·Jari TiihonenPasi Korhonen
Apr 13, 2011·Annals of General Psychiatry·Larry AlphsNorris Turner
Dec 20, 2011·Clinical Therapeutics·Christoph U CorrellJohn M Kane
Sep 12, 2012·Schizophrenia Research and Treatment·Simon Zhornitsky, Emmanuel Stip
Oct 12, 2013·International Clinical Psychopharmacology·Dong-Jing FuLarry Alphs
Nov 21, 2013·Early Intervention in Psychiatry·Shi Mei KamRachel Upthegrove
Nov 23, 2013·Patient Preference and Adherence·Gabriel KaplanJacqueline Zummo
Dec 20, 2013·Neuropsychiatric Disease and Treatment·Nagahide TakahashiTaka Matsumura
May 30, 2014·Schizophrenia Bulletin·Peter F BuckleyUNKNOWN PROACTIVE Study
Nov 2, 2014·Therapeutic Advances in Psychopharmacology·Sofia BrissosVicent Balanzá-Martinez
Jan 6, 2015·Schizophrenia Research·Jun IshigookaUNKNOWN ALPHA Study Group
Jan 7, 2015·The Journal of Clinical Psychiatry·Dong-Jing FuLarry Alphs
Feb 20, 2015·Annals of General Psychiatry·Markella FisteIoannis Liappas
Mar 21, 2015·Neuropsychiatric Disease and Treatment·Fan ZhangSteve Ascher
Mar 25, 2015·Journal of Medical Economics·K JoshiD J Fu
Mar 31, 2015·JAMA Psychiatry·Joris BerwaertsDavid W Hough
Apr 25, 2015·Pharmacoepidemiology and Drug Safety·Nicole PrattElizabeth E Roughead
May 6, 2015·The Journal of Clinical Psychiatry·Larry AlphsH Lynn Starr
Oct 4, 2015·Schizophrenia Research·Andreas SchreinerLudger Hargarter
Apr 5, 2016·Expert Opinion on Pharmacotherapy·L HargarterA Schreiner
Jun 4, 2016·CNS Drugs·Eduard Parellada, Miquel Bioque
Jun 9, 2017·JAMA Psychiatry·Jari TiihonenHeidi Taipale
Aug 18, 2017·International Clinical Psychopharmacology·Robin EmsleyMarta García-Dorado
Nov 5, 2017·Advances in Therapy·Hongyan ZhangYu Feng
Feb 21, 2019·JAMA Psychiatry·Jari TiihonenAntti Tanskanen